Thyroid Medication recalls

The FDA has published 242 recalls involving thyroid medication since 2012. The latest was reported on 23 Sep 2026. Most were for potency & assay. Accord Healthcare has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls242since 2012

Last 12 months30reported

Class I2611% of total

Ongoing63latest 23 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 18 1 0Feb 2 0 4May 1 7 1Aug 0 1 0Nov 0 2 0Feb 0 1 0May 0 13 0Aug 13 0

Severity split

Class I 26 11%Class II 213 88%Class III 3 1%

Why thyroid medication is recalled

Companies

Accord Healthcare2611%
RLC Labs2410%
Aidapak Services208%
Lloyd Inc. of Iowa187%
Ibsa Pharma156%
Pfizer146%
Major Pharmaceuticals125%
King Legacy, a wholly owned subsidiary of Pfizer115%

Brands

By year

20262912%
2025177%
2024219%
2023219%
202194%
20204017%
201942%
2018177%
201721%
201652%

Ongoing thyroid medication recalls

63 active

Reported	Class	Recall	Company	Reason	Where
23 Sep 2026Drug	CLASS I	Thyroid Tablets, USP, 1/2 Grain (30 mg) recalledThyroid	Vitruvias Therapeutics	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide

All thyroid medication recalls, newest first

242 total

Reported	Class	Recall	Company	Reason	Where
23 Sep 2026Drug	CLASS I	Thyroid Tablets, USP, 1/2 Grain (30 mg) recalledThyroid	Vitruvias Therapeutics	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
8 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
1 Apr 2026Drug	CLASS II	Levothyroxine Sodium Tablets USP 150 mcg recalled by Macleods Pharma UsaLevothyroxine Sodium	Macleods Pharma USA	Potency & Assay	Nationwide
28 Jan 2026Drug	CLASS II	Thyroid recalled by Specialty Process Labs	Specialty Process Labs	Potency & Assay	Nationwide
21 Jan 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg recalled	Alvogen	Packaging Defects	Nationwide
15 Oct 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide

Should you stop taking Thyroid Medication?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.

Alert me about Thyroid Medication

One email the day a new recall is posted for Thyroid Medication. Unsubscribe any time.

At a glance

Latest recall: 23 Sep 2026
First on record: 4 Jul 2012
Class I share: 11%
Ongoing: 63

Drug classes

Injectable & IV Drugs 4,623Pain Medication 1,518Creams, Ointments & Gels 928Blood Pressure Medication 837Compounded Drugs 721Eye Drops 600Hormones & Birth Control 494Antibiotics 492Allergy Medication 348Stomach & Acid Reflux Medication 313Cold & Cough Medicine 312Diabetes Medication 242

Recall classes

CLASS ISerious harm or death possible.

CLASS IITemporary or reversible harm.

CLASS IIIUnlikely to cause harm.